TrialJournal of cancer research and clinical oncology2023

Efficacy and safety of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer: a prospective, single-arm, phase II study in China.

Xiao Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.